Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA extends review on Novartis oral MS drug by three months
FDA extends review on Novartis oral MS drug by three months
FDA extends review on Novartis oral MS drug by three months
Submitted by
admin
on May 25, 2010 - 9:02am
Source:
Pharma Times, UK
News Tags:
FDA
Novartis
MS
multiple sclerosis
Gilenia
Headline:
FDA extends review on Novartis oral MS drug by three months
Do Not Allow Advertisers to Use My Personal information
